Topically applied midodrine, 0.2%, an α1-agonist, for the treatment of erythromelalgia

Mark D.P. Davis; Claudia S. Morr; Roger A. Warndahl; Paola Sandroni

doi:10.1001/jamadermatol.2015.0511

Topically applied midodrine, 0.2%, an α₁-agonist, for the treatment of erythromelalgia

Mark D.P. Davis, Claudia S. Morr, Roger A. Warndahl, Paola Sandroni

Neurology

Research output: Contribution to journal › Letter › peer-review

10 Scopus citations

Original language	English (US)
Pages (from-to)	1025-1026
Number of pages	2
Journal	JAMA Dermatology
Volume	151
Issue number	9
DOIs	https://doi.org/10.1001/jamadermatol.2015.0511
State	Published - Sep 1 2015

ASJC Scopus subject areas

Dermatology

Access to Document

10.1001/jamadermatol.2015.0511

Cite this

@article{5c24066a88bb40aa9bbc187d3ff9cb09,

title = "Topically applied midodrine, 0.2%, an α1-agonist, for the treatment of erythromelalgia",

author = "Davis, {Mark D.P.} and Morr, {Claudia S.} and Warndahl, {Roger A.} and Paola Sandroni",

year = "2015",

month = sep,

day = "1",

doi = "10.1001/jamadermatol.2015.0511",

language = "English (US)",

volume = "151",

pages = "1025--1026",

journal = "JAMA Dermatology",

issn = "2168-6068",

publisher = "American Medical Association",

number = "9",

}

TY - JOUR

T1 - Topically applied midodrine, 0.2%, an α1-agonist, for the treatment of erythromelalgia

AU - Davis, Mark D.P.

AU - Morr, Claudia S.

AU - Warndahl, Roger A.

AU - Sandroni, Paola

PY - 2015/9/1

Y1 - 2015/9/1

UR - http://www.scopus.com/inward/record.url?scp=84941313107&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84941313107&partnerID=8YFLogxK

U2 - 10.1001/jamadermatol.2015.0511

DO - 10.1001/jamadermatol.2015.0511

M3 - Letter

C2 - 25946117

AN - SCOPUS:84941313107

SN - 2168-6068

VL - 151

SP - 1025

EP - 1026

JO - JAMA Dermatology

JF - JAMA Dermatology

IS - 9

ER -

Topically applied midodrine, 0.2%, an α1-agonist, for the treatment of erythromelalgia

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this

Topically applied midodrine, 0.2%, an α₁-agonist, for the treatment of erythromelalgia